{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:07:28Z","timestamp":1792807648952,"version":"4.5.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2021,1,1]]},"DOI":"10.1001\/jamaneurol.2020.3836","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T15:48:55Z","timestamp":1603122535000},"page":"11","source":"Crossref","is-referenced-by-count":41,"title":["Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source"],"prefix":"10.1001","volume":"78","author":[{"given":"Ashkan","family":"Shoamanesh","sequence":"first","affiliation":[{"name":"Division of Neurology, McMaster University \/ Population Health Research Institute, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Hart","sequence":"additional","affiliation":[{"name":"Division of Neurology, McMaster University \/ Population Health Research Institute, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart J.","family":"Connolly","sequence":"additional","affiliation":[{"name":"Division of Neurology, McMaster University \/ Population Health Research Institute, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Kasner","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric E.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Mart\u00ed-F\u00e0bregas","sequence":"additional","affiliation":[{"name":"Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Yun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Statistics, Population Health Research Institute, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Uchiyama","sequence":"additional","affiliation":[{"name":"Department of Neurology, Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Mikulik","sequence":"additional","affiliation":[{"name":"International Clinical Research Center and Department of Neurology, St. Anne\u2019s University Hospital and Masaryk University, Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Veltkamp","sequence":"additional","affiliation":[{"name":"Department of Neurology, Imperial College Healthcare NHS Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"O\u2019Donnell","sequence":"additional","affiliation":[{"name":"Division of Neurology, McMaster University \/ Population Health Research Institute, Hamilton, Ontario, Canada"},{"name":"Department of Medicine, National University of Ireland Galway, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Ntaios","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Thessaly, Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith W.","family":"Muir","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience & Psychology, University of Glasgow, Glasgow, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thalia S.","family":"Field","sequence":"additional","affiliation":[{"name":"Division of Neurology, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo C.","family":"Santo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospitais da Universidade de Coimbra, Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Olavarria","sequence":"additional","affiliation":[{"name":"Department of Neurology and Psychiatry, Cl\u00ednica Alemana de Santiago, Facultad de Medicina, Cl\u00ednica Alemana Universidad del Desarrollo, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardi","family":"Mundl","sequence":"additional","affiliation":[{"name":"Pharmaceuticals Development, TA Cardiovascular, Bayer Pharma AG, Wuppertal, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmi","family":"Lutsep","sequence":"additional","affiliation":[{"name":"Department of Neurology, Oregon Health and Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Berkowitz","sequence":"additional","affiliation":[{"name":"Thrombosis Group, Pharmaceuticals Research and Development, Bayer, Whippany, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukul","family":"Sharma","sequence":"additional","affiliation":[{"name":"Division of Neurology, McMaster University \/ Population Health Research Institute, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"noi200075r1","doi-asserted-by":"crossref","DOI":"10.1177\/1747493017751931","article-title":"Clinical significance of cerebral microbleeds on MRI: a comprehensive meta-analysis of risk of intracerebral hemorrhage, ischemic stroke, mortality, and dementia in cohort studies (v1).","author":"Charidimou","year":"2018;","journal-title":"Int J Stroke"},{"issue":"3","key":"noi200075r2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1161\/STROKEAHA.116.015354","article-title":"Cerebral microbleeds as predictors of mortality: the Framingham Heart Study.","volume":"48","author":"Romero","year":"2017","journal-title":"Stroke"},{"key":"noi200075r3","author":"Wilson","year":"2019;","journal-title":"Lancet Neurol"},{"issue":"6","key":"noi200075r4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1474-4422(18)30145-5","article-title":"Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study.","volume":"17","author":"Wilson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"12","key":"noi200075r5","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1161\/STROKEAHA.117.018467","article-title":"Should patients with ischemic stroke or transient ischemic attack with atrial fibrillation and microbleeds be anticoagulated?","volume":"48","author":"Shoamanesh","year":"2017","journal-title":"Stroke"},{"issue":"3","key":"noi200075r6","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/2396987316663049","article-title":"Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: design of the NAVIGATE ESUS randomized trial.","volume":"1","author":"Hart","year":"2016","journal-title":"Eur Stroke J"},{"issue":"23","key":"noi200075r7","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source.","volume":"378","author":"Hart","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"noi200075r8","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.01.027","article-title":"Characterization of patients with embolic strokes of undetermined source in the NAVIGATE ESUS randomized trial.","volume":"27","author":"Kasner","year":"2018","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"noi200075r9","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ana.24988","article-title":"Microbleeds in the Secondary Prevention Of Small Subcortical Strokes trial: stroke, mortality, and treatment interactions.","volume":"82","author":"Shoamanesh","year":"2017","journal-title":"Ann Neurol"},{"key":"noi200075r10","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2018.0454","article-title":"Cerebral microbleeds and the effect of intensive blood pressure reduction on hematoma expansion and functional outcomes: a secondary analysis of the ATACH-2 randomized clinical trial.","author":"Shoamanesh","year":"2018","journal-title":"JAMA Neurol"},{"key":"noi200075r11","article-title":"Ischemic lesions, blood pressure dysregulation, and poor outcomes in intracerebral hemorrhage.","author":"Kidwell","year":"2017","journal-title":"Neurology"},{"key":"noi200075r12","author":"Oliveira-Filho","year":"2018","journal-title":"J Neuroimaging"},{"issue":"14","key":"noi200075r13","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/WNL.0000000000003183","article-title":"Recurrent stroke risk and cerebral microbleed burden in ischemic stroke and TIA: a meta-analysis.","volume":"87","author":"Wilson","year":"2016","journal-title":"Neurology"},{"issue":"7","key":"noi200075r14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1474-4422(19)30184-X","article-title":"Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial.","volume":"18","author":"Al-Shahi Salman","year":"2019","journal-title":"Lancet Neurol"},{"issue":"2","key":"noi200075r15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00415-015-7966-2","article-title":"The clinical relevance of cerebral microbleeds in patients with cerebral ischemia and atrial fibrillation.","volume":"263","author":"Haji","year":"2016","journal-title":"J Neurol"},{"key":"noi200075r16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jns.2016.08.050","article-title":"Cerebral microbleeds and white matter hyperintensities in cardioembolic stroke patients due to atrial fibrillation: single-centre longitudinal study.","volume":"369","author":"Charidimou","year":"2016","journal-title":"J Neurol Sci"},{"issue":"15","key":"noi200075r17","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1212\/WNL.0000000000000862","article-title":"Association of cerebral microbleeds with mortality in stroke patients having atrial fibrillation.","volume":"83","author":"Song","year":"2014","journal-title":"Neurology"},{"issue":"21","key":"noi200075r18","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/CIRCULATIONAHA.110.004747","article-title":"Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.","volume":"123","author":"Eikelboom","year":"2011","journal-title":"Circulation"},{"issue":"9921","key":"noi200075r19","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"issue":"12","key":"noi200075r20","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation.","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"issue":"11","key":"noi200075r21","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation.","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"issue":"10","key":"noi200075r22","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"22","key":"noi200075r23","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation.","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"noi200075r24","doi-asserted-by":"crossref","DOI":"10.1253\/circj.CJ-12-0454","article-title":"Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation - the J-ROCKET AF study.","author":"Hori","year":"2012","journal-title":"Circ J"},{"key":"noi200075r25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ahj.2016.03.019","article-title":"Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study.","volume":"178","author":"O\u2019Donnell","year":"2016","journal-title":"Am Heart J"},{"issue":"12","key":"noi200075r26","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"issue":"9","key":"noi200075r27","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation.","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"noi200075r28","first-page":"360","article-title":"Understanding interobserver agreement: the kappa statistic.","volume":"37","author":"Viera","year":"2005","journal-title":"Fam Med"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2771829\/jamaneurology_shoamanesh_2020_oi_200075_1610037501.12739.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T16:27:52Z","timestamp":1610641672000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2771829"}},"subtitle":["An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2021,1,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2020.3836","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,1]]}}}